Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 4/20 | 1.00 |
| ▸ | TP53 | P04637 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | CASP1 | P29466 | 3/20 | 1.00 |
| ▸ | CASP7 | P55210 | 3/20 | 1.00 |
| ▸ | HBB | P68871 | 3/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | BRCA1 | P38398 | 2/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 2/20 | 1.00 |
| ▸ | NPC1 | O15118 | 1/20 | 1.00 |
| ▸ | PRNP | P04156 | 1/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 1/20 | 1.00 |
| ▸ | CHRM4 | P08173 | 1/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 1/20 | 1.00 |
| ▸ | HTR1A | P08908 | 1/20 | 1.00 |
| ▸ | CHRM5 | P08912 | 1/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Quinacrine SCHEMBL29363141 | 1.00 | USP2 (1.00) | USP2TP53CYP3A4CASP1CASP7 | |
| Quinacrine SCHEMBL19225 | 1.00 | USP2 (1.00) | USP2TP53CYP3A4CASP1CASP7 | |
| Quinacrine SCHEMBL29717736 | 1.00 | USP2 (1.00) | USP2TP53CYP3A4CASP1CASP7 | |
| Quinacrine SCHEMBL17704776 | 1.00 | USP2 (1.00) | USP2TP53CYP3A4CASP1CASP7 | |
| Quinacrine SCHEMBL1817364 | 1.00 | USP2 (1.00) | USP2TP53CYP3A4CASP1CASP7 | |
| Quinacrine SCHEMBL33693 | 0.99 | USP2 (1.00) | USP2TP53CYP3A4CASP1CASP7 | |
| Quinacrine SCHEMBL30153780 | 0.99 | USP2 (1.00) | USP2TP53CYP3A4CASP1CASP7 | |
| Quinacrine SCHEMBL15061349 | 0.99 | USP2 (1.00) | USP2TP53CYP3A4CASP1CASP7 | |
| Quinacrine SCHEMBL162379 | 0.99 | USP2 (1.00) | USP2TP53CYP3A4CASP1CASP7 | |
| Quinacrine SCHEMBL28651594 | 0.99 | USP2 (0.98) | USP2TP53CYP3A4CASP1CASP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3626 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240398801-A1 | TREATMENT OF LEUKEMIA BASED ON LEUKEMIA HIERARCHY IN A PATIENT | UNIVERSITY HEALTH NETWORK (CA) | 2024-12-05 | — | — | US | claimed |
| WO-2024085332-A1 | ANTIBODY-BOUND METAL-ORGANIC FRAMEWORK AND ANTICANCER COMPOSITION COMPRISING SAME | 울산과학기술원 | 2024-04-25 | — | — | WO | claimed |
| WO-2023164252-A1 | ISOTHERMAL NUCLEIC ACID DETECTION ASSAYS AND USES THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2023-08-31 | — | — | WO | claimed |
| US-20230241057-A1 | COMPOUNDS FOR THE PREVENTION, TREATMENT AND DIAGNOSIS OF THROMBI | UNIVERSITE PARIS 13 PARIS-NORD (FR) | 2023-08-03 | — | — | US | claimed |
| WO-2023050018-A1 | TREATMENT OF LEUKEMIA BASED ON LEUKEMIA HIERARCHY IN A PATIENT | UNIVERSITY HEALTH NETWORK (CA) | 2023-04-06 | — | — | WO | claimed |
| EP-4157282-A1 | COMPOUNDS FOR THE PREVENTION, TREATMENT AND DIAGNOSIS OF THROMBI | Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) | 2023-04-05 | — | — | EP | claimed |
| WO-2021239905-A1 | COMPOUNDS FOR THE PREVENTION, TREATMENT AND DIAGNOSIS OF THROMBI | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2021-12-02 | — | — | WO | claimed |
| CN-112745832-A | Method for preparing fluorescent anti-counterfeiting material | 大连理工大学 | 2021-05-04 | — | — | CN | claimed |
| CN-110227061-B | Nanogel containing platinum nanoparticles, and preparation method and application thereof | 中国医学科学院基础医学研究所 | 2021-01-29 | — | — | CN | claimed |
| WO-2020242217-A1 | LIPOSOME COMPRISING GLUTATHIONE-S-TRANSFERASE AND PROTEIN HAVING CAPACITY TO BIND TO TARGET CELL OR TARGET PROTEIN, AND USE THEREOF | 울산과학기술원 | 2020-12-03 | — | — | WO | claimed |
| CN-1655817-A | Oxygenating agents for enhancing host responses to microbial infections | EXPONENTIAL BIOTHERAPIES INC (US) | 2005-08-17 | — | — | CN | claimed |
| EP-1519750-A2 | OXYGENATING AGENTS FOR ENHANCING HOST RESPONSES TO MICROBIAL INFECTIONS | Exponential Biotherapies, Inc. (US) | 2005-04-06 | — | — | EP | claimed |
| WO-2003082392-A2 | OXYGENATING AGENTS FOR ENHANCING HOST RESPONSES TO MICROBIAL INFECTIONS | EXPONENTIAL BIOTHERAPIES, INC. (US) | 2003-10-09 | — | — | WO | claimed |
| CN-1359288-A | Improved method of transport across an adaptable semi-permeable barrier | IDEA AG (DE) | 2002-07-17 | — | — | CN | claimed |
| JP-2001527390-A | — | — | 2001-12-25 | — | — | JP | claimed |
| EP-1011655-A1 | INHIBITORS OF LEADERLESS PROTEIN EXPORT | Ciblex Corporation (US) | 2000-06-28 | — | — | EP | claimed |
| CN-1252716-A | Inhibitors of leaderless protein export | CIBLEX CORP (US) | 2000-05-10 | — | — | CN | claimed |
| US-5827681-A | Rapid detection and drug sensitivity of malaria | UNIVERSITY TECHNOLOGY CORPORATION (US) | 1998-10-27 | — | — | US | claimed |
| WO-1998037880-A1 | INHIBITORS OF LEADERLESS PROTEIN EXPORT | CIBLEX CORPORATION (US) | 1998-09-03 | — | — | WO | claimed |
| EP-0003583-B1 | COMPOSITIONS FOR CYTOCHEMICAL INVESTIGATION, THEIR USE AND METHOD FOR THE DETECTION OF STEROID HORMONE RECEPTORS IN HUMAN TISSUES | Lee, Sin Hang (US) | 1981-12-02 | — | — | EP | claimed |